<DOC>
	<DOC>NCT01349998</DOC>
	<brief_summary>The purpose of this study is to examine the long-term safety of treating recurrent episodes of tinea pedis for 14 days for each recurrence and recurrent episodes of tinea corporis or tinea cruris for 7 days for each recurrence with Product 33525.</brief_summary>
	<brief_title>Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<criteria>Evidence of tinea cruris, tinea pedis, or tinea corporis. Additional criteria listed in protocol Pregnancy and allergies. Additional criteria listed in protocol</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>